Search research articles
Contact Us
Filters
Showing results (111-120 of 349) with videos related to
Page
of 35
Sort By:
Oncology
|
February 23, 2022
Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor
Bo Mi Ku, Yeon Jeong Kim, Donghyun Park, et al.
Oncotarget
|
September 30, 2016
Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery
Won Kyung Cho, Dongryul Oh, Yong Chan Ahn, et al.
Oncotarget
|
October 6, 2017
Mutational status of <i>TP53</i> defines the efficacy of Wee1 inhibitor AZD1775 in <i>KRAS</i>-mutant non-small cell lung cancer
Bo Mi Ku, Yeon-Hee Bae, Jiae Koh, et al.
Cancer Medicine
|
February 7, 2020
PD-1 inhibitors for non-small cell lung cancer patients with special issues: Real-world evidence
Seonggyu Byeon, Jang Ho Cho, Hyun Ae Jung, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 7, 2020
Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary pleomorphic carcinoma
Jiyun Lee, Yoon La Choi, Hyun Ae Jung, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 14, 2003
Decreased anxiety, altered place learning, and increased CA1 basal excitatory synaptic transmission in mice with conditional ablation of the neural cell adhesion molecule L1
Janice W S Law, Alan Y W Lee, Mu Sun, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2025
Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung cancer with EGFR exon 20 insertion treated with amivantamab
Geun-Ho Park, Sehhoon Park, Hyemin Kim, et al.
Investigational New Drugs
|
April 6, 2016
AZD9291 overcomes T790 M-mediated resistance through degradation of EGFR(L858R/T790M) in non-small cell lung cancer cells
Bo Mi Ku, Yeon-Hee Bae, Jiae Koh, et al.
Frontiers in Oncology
|
June 4, 2026
Paired ctDNA analysis reveals diverse resistance mechanisms to mobocertinib in EGFR exon 20 insertion NSCLC
Jinyong Kim, Geun-Ho Park, Sehhoon Park, et al.
Cancer Research and Treatment
|
July 1, 2020
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation
Sehhoon Park, Bo Mi Ku, Hyun Ae Jung, et al.
Page
of 35
Search research articles
Search
Showing results (111-120 of 349) with videos related to
Sort By:
Page
of 35
Oncology
|
February 23, 2022
Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor
Bo Mi Ku, Yeon Jeong Kim, Donghyun Park, et al.
Oncotarget
|
September 30, 2016
Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery
Won Kyung Cho, Dongryul Oh, Yong Chan Ahn, et al.
Oncotarget
|
October 6, 2017
Mutational status of <i>TP53</i> defines the efficacy of Wee1 inhibitor AZD1775 in <i>KRAS</i>-mutant non-small cell lung cancer
Bo Mi Ku, Yeon-Hee Bae, Jiae Koh, et al.
Cancer Medicine
|
February 7, 2020
PD-1 inhibitors for non-small cell lung cancer patients with special issues: Real-world evidence
Seonggyu Byeon, Jang Ho Cho, Hyun Ae Jung, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 7, 2020
Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary pleomorphic carcinoma
Jiyun Lee, Yoon La Choi, Hyun Ae Jung, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 14, 2003
Decreased anxiety, altered place learning, and increased CA1 basal excitatory synaptic transmission in mice with conditional ablation of the neural cell adhesion molecule L1
Janice W S Law, Alan Y W Lee, Mu Sun, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2025
Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung cancer with EGFR exon 20 insertion treated with amivantamab
Geun-Ho Park, Sehhoon Park, Hyemin Kim, et al.
Investigational New Drugs
|
April 6, 2016
AZD9291 overcomes T790 M-mediated resistance through degradation of EGFR(L858R/T790M) in non-small cell lung cancer cells
Bo Mi Ku, Yeon-Hee Bae, Jiae Koh, et al.
Frontiers in Oncology
|
June 4, 2026
Paired ctDNA analysis reveals diverse resistance mechanisms to mobocertinib in EGFR exon 20 insertion NSCLC
Jinyong Kim, Geun-Ho Park, Sehhoon Park, et al.
Cancer Research and Treatment
|
July 1, 2020
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation
Sehhoon Park, Bo Mi Ku, Hyun Ae Jung, et al.
Page
of 35